ARS Pharmaceuticals Overview
ARS Pharmaceuticals Target Price
Analysts' 12-month price predictions for SPRY.
Get informed when a big investor buys or sells
+ FollowShare Price
$8.56
Average Target Price
$25.50
197.9% upside
197.9% upside2 analysts in the last 4 months
High: $26 | Low: $25
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-04-09 | Northland Securities | $25 | 192.1% upside |  |
| 2026-03-10 | Leerink PartnersRoanna Ruiz | $26 | 203.7% upside | |
| 2025-11-04 | Roth CapitalKyle Bauser | $30 | 250.5% upside | |
| 2025-09-26 | Raymond James | $32 | 273.8% upside | |
| 2024-08-19 | Cantor FitzgeraldJosh Schimmer | $30 | 250.5% upside | |
| 2024-08-12 | Raymond JamesStrong Buy | $22 | 157% upside | |
| 2024-07-25 | Raymond JamesRyan Deschner | $18 | 110.3% upside | |
| 2024-03-05 | Leerink PartnersRoanna Ruiz | $18 | 110.3% upside | |
| 2022-12-13 | Leerink Partners | $14 | 63.6% upside | |